Literature DB >> 23060933

Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus.

Sema Uslu1, Nur Kebapçi, Mehmet Kara, Cengiz Bal.   

Abstract

The aim of this study was to explore the relationship between serum profiles of adiponectin, leptin, resistin and visfatin and traditional and non-traditional cardiovascular risk factors in patients with type 2 diabetes mellitus (T2DM). A total of 85 patients with T2DM and 30 non-diabetic controls were enrolled in the study. Levels of adipocytokines (adiponectin, leptin, resistin and visfatin), lipids (total cholesterol, triglycerides), lipoproteins [HDL-cholesterol, LDL-cholesterol, lipoprotein (a)], apolipoproteins (Apo-A1 and Apo-B), non-traditional cardiovascular risk markers [asymmetric dimethylarginine (ADMA), homocysteine] and the inflammatory marker hs-CRP were measured, and anthropometric variables were determined. Serum adiponectin levels were decreased and leptin, resistin and visfatin levels were increased in T2DM patients compared to controls. They were associated with obesity (BMI), insulin resistance (HOMA-IR) and various markers of glucose/lipid profile, inflammation and endothelial dysfunction markers. These results suggest that decreased serum adiponectin and increased leptin, resistin and visfatin levels in T2DM may be novel biochemical risk factors for cardiovascular complications.

Entities:  

Year:  2012        PMID: 23060933      PMCID: PMC3460256          DOI: 10.3892/etm.2012.557

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  49 in total

1.  Associations between leptin and the leptin / adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA / KORA Augsburg study 1984-2002.

Authors:  B Thorand; A Zierer; J Baumert; C Meisinger; C Herder; W Koenig
Journal:  Diabet Med       Date:  2010-09       Impact factor: 4.359

2.  Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus.

Authors:  Ippei Kanazawa; Shozo Yano; Yoshitomo Notsu; Toru Yamaguchi; Toru Nabika; Toshitsugu Sugimoto
Journal:  Clin Endocrinol (Oxf)       Date:  2011-04       Impact factor: 3.478

3.  Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.

Authors:  Miao-Pei Chen; Fu-Mei Chung; Dao-Ming Chang; Jack C-R Tsai; Han-Fen Huang; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  J Clin Endocrinol Metab       Date:  2005-10-18       Impact factor: 5.958

Review 4.  Role of resistin in obesity, insulin resistance and Type II diabetes.

Authors:  Christine M Kusminski; Philip G McTernan; Sudhesh Kumar
Journal:  Clin Sci (Lond)       Date:  2005-09       Impact factor: 6.124

5.  Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes.

Authors:  Muredach P Reilly; Nayyar Iqbal; Mark Schutta; Megan L Wolfe; Monique Scally; A Russell Localio; Daniel J Rader; Stephen E Kimmel
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

6.  Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients.

Authors:  Aysen Akalin; Ozkan Alatas; Omer Colak
Journal:  Eur J Endocrinol       Date:  2008-01       Impact factor: 6.664

7.  Homocysteine upregulates resistin production from adipocytes in vivo and in vitro.

Authors:  Yin Li; Changtao Jiang; Guoheng Xu; Nanping Wang; Yi Zhu; Chaoshu Tang; Xian Wang
Journal:  Diabetes       Date:  2008-01-11       Impact factor: 9.461

8.  The ratio of leptin to adiponectin can be used as an index of insulin resistance.

Authors:  Naohisa Oda; Shigeo Imamura; Takashi Fujita; Yuka Uchida; Kazumichi Inagaki; Hiroaki Kakizawa; Nobuki Hayakawa; Atsushi Suzuki; Jun Takeda; Yukio Horikawa; Mitsuyasu Itoh
Journal:  Metabolism       Date:  2008-02       Impact factor: 8.694

Review 9.  ADMA, cardiovascular disease and diabetes.

Authors:  Katarzyna Krzyzanowska; Friedrich Mittermayer; Michael Wolzt; Guntram Schernthaner
Journal:  Diabetes Res Clin Pract       Date:  2008-10-30       Impact factor: 5.602

Review 10.  Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Shanshan Li; Hyun Joon Shin; Eric L Ding; Rob M van Dam
Journal:  JAMA       Date:  2009-07-08       Impact factor: 56.272

View more
  24 in total

1.  An assessment of correlation between serum asymmetric dimethylarginine and glycated haemoglobin in patients with type 2 diabetes mellitus.

Authors:  Asja Začiragić; Jasminko Huskić; Nedžad Mulabegović; Nesina Avdagić; Amina Valjevac; Sabaheta Hasić; Radivoj Jadrić
Journal:  Bosn J Basic Med Sci       Date:  2014-02       Impact factor: 3.363

2.  Pain Intensity and Pain Interference in Older Adults: Role of Gender, Obesity and High-Sensitivity C-Reactive Protein.

Authors:  Vahid Eslami; Mindy J Katz; Robert S White; Erin Sundermann; Julie M Jiang; Ali Ezzati; Richard B Lipton
Journal:  Gerontology       Date:  2016-08-04       Impact factor: 5.140

3.  Circulating levels of apelin, glucagon-like peptide and visfatin in hypercholesterolemic-hyperhomocysteinemic guinea-pigs: their relation with NO metabolism.

Authors:  Zeynep Kusku-Kiraz; Sema Genc; Seldag Bekpinar; Yesim Unlucerci; Vakur Olgac; Mujdat Uysal; Figen Gurdol
Journal:  Mol Cell Biochem       Date:  2014-11-08       Impact factor: 3.396

Review 4.  Effect of periodontal treatment on adipokines in type 2 diabetes.

Authors:  Hiroshi Ogawa; Teerasak Damrongrungruang; Sayaka Hori; Kaname Nouno; Kumiko Minagawa; Misuzu Sato; Hideo Miyazaki
Journal:  World J Diabetes       Date:  2014-12-15

5.  Resistin polymorphims, plasma resistin levels and obesity in Tunisian volunteers.

Authors:  Nesrine Zayani; Haithem Hamdouni; Imen Boumaiza; Ons Achour; Fadoua Neffati; Asma Omezzine; Mohamed Fadhel Najjar; Ali Bouslama
Journal:  J Clin Lab Anal       Date:  2017-04-10       Impact factor: 2.352

6.  Association of resistin polymorphisms with resistin levels and lipid profile in children.

Authors:  Lorena Ortega; Pilar Navarro; Pía Riestra; Teresa Gavela-Pérez; Leandro Soriano-Guillén; Carmen Garcés
Journal:  Mol Biol Rep       Date:  2014-08-06       Impact factor: 2.316

7.  Leptin's activity on the hydroxyl radical: a possible link to the oxidative stress-related endothelial vasodilation in patients with obstructive sleep apnea.

Authors:  Madalina Macrea; Thomas Martin; Zhenquan Jia; Hara Misra
Journal:  Lung       Date:  2013-05-21       Impact factor: 2.584

8.  Secretion of one adipokine Nampt/Visfatin suppresses the inflammatory stress-induced NF-κB activity and affects Nampt-dependent cell viability in Huh-7 cells.

Authors:  Yi-Ching Lin; Hui-Chung Wu; Chen-Chung Liao; Yi-Chih Chou; Shwu-Fen Pan; Chi-Ming Chiu
Journal:  Mediators Inflamm       Date:  2015-02-26       Impact factor: 4.711

Review 9.  Visfatin/Nampt: an adipokine with cardiovascular impact.

Authors:  Tania Romacho; Carlos F Sánchez-Ferrer; Concepción Peiró
Journal:  Mediators Inflamm       Date:  2013-06-16       Impact factor: 4.711

10.  Association of adipokines and adhesion molecules with indicators of obesity in women undergoing mammography screening.

Authors:  Caroline Isoppo de Souza; Daniela Dornelles Rosa; Betina Ettrich; Gabriela Hermann Cibeira; Juliana Giacomazzi; Paloma Tusset; Patrícia Ashton-Prolla; Lidia Rosi Medeiros; Maira Caleffi; Eurico Camargo Neto; Emilio Hideyuki Moriguchi; Marcia Silveira Graudenz
Journal:  Nutr Metab (Lond)       Date:  2012-10-31       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.